A novel dRYBP-SCF complex functions to inhibit apoptosis in Drosophila

Sol Fereres1, Rocío Simón, Ana Busturia

  • 1Centro de Biología Molecular "Severo Ochoa" CSIC-UAM, c/Nicolás Cabrera 1, 28049, Madrid, Spain.

Insights

The Drosophila RYBP-SCF complex, involving SKPA, genetically and biochemically inhibits apoptosis. Loss of SKPA activates intrinsic apoptosis, down-regulating DIAP1, but this is rescued by inhibiting pro-apoptotic genes.

Area of Science:

  • Cell Biology
  • Developmental Biology
  • Genetics

Background:

  • Apoptosis regulation is vital for development and survival.
  • Protein ubiquitylation is a key mechanism controlling apoptotic factor levels.
  • The SCF (Skip, Cullin, F-box) complex is an E3 ubiquitin ligase involved in protein degradation.

Purpose of the Study:

  • To investigate the role of Drosophila RYBP (dRYBP) in apoptosis.
  • To determine the interaction between dRYBP and the SKPA-containing SCF complex.
  • To elucidate the mechanisms by which this complex regulates apoptosis.

Main Methods:

  • Genetic interaction studies in Drosophila.
  • Biochemical assays to confirm protein interactions.
  • Analysis of apoptosis pathways (intrinsic and extrinsic).
  • Gene expression analysis of apoptotic factors (e.g., DIAP1).
  • Rescue experiments using genetic manipulations.

Main Results:

  • dRYBP interacts with the SKPA-containing SCF complex to inhibit apoptosis.
  • Loss of SKPA function leads to intrinsic apoptosis and decreased DIAP1 levels.
  • Apoptosis induced by skpA or dRYBP inactivation is rescued by inhibiting reaper or overexpressing DIAP1.
  • Overexpression of SKPA rescues Reaper-induced wing phenotypes and inhibits developmental/radiation-induced apoptosis.

Conclusions:

  • The dRYBP-SCF complex inhibits apoptosis, likely by ubiquitylation and proteasomal degradation of pro- and anti-apoptotic proteins.
  • These findings suggest conserved roles for dRYBP and SCF homologs in balancing cell survival and death.
  • This has implications for understanding normal and pathological development in mammals.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...